Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets.
Nakagawa Suguru, Usui Tomohiko, Yokoo Seiichi, Omichi Sachiko, Kimakura Mikiko, Mori Yosai, Miyata Kazunori, Aihara Makoto, Amano Shiro, Araie Makoto
AI Summary
This study found BAC-containing glaucoma drops are most toxic to corneal cells; formulations with lower BAC (0.001%) or non-BAC preservatives like sofZia are less damaging to the eye surface.
Abstract
Purpose
To investigate the toxicity profiles of seven antiglaucoma topical eye drops and benzalkonium chloride (BAC) using stratified cultivated human corneal epithelial cell sheets (HCES) in a serum-free culture system.
Methods
A range of prostaglandin analogies and preservatives, including BAC, sofZia (SZ), sodium benzoate (SB), and polyquaternium-1 (PQ) were tested. The barrier function and cell viability were examined by a carboxyfluorescein permeability assay and WST-1 assay. Histological evaluation of the HCES was also performed after application of each solution.
Results
The carboxyfluorescein permeability assay had a higher sensitivity for the detection of toxicity of test solutions than the WST-1 assay or histological examination. Latanoprost BAC, latanoprost/timolol BAC, and 0.02% or higher concentration of BAC were the most toxic, followed by latanoprost SB, latanoprost preservative-free, BAC 0.002%, and travoprost/ latanoprost PQ. Travoprost SZ and tafluprost BAC (preserved with 0.001% BAC) was the least toxic in our experimental conditions.
Conclusions
The carboxyfluorescein permeability assay using HCES in a serum-free system was the most useful for the quantification of toxicity of ophthalmic solutions. Among the regimens examined, a BAC concentration of 0.001% or lower or non-BAC preservative sofZia was suggested to be the least toxic to the ocular surface.
MeSH Terms
Shields Classification
Related Articles5
Reticular Epithelial Edema: An Uncommon Side Effect of ROCK/NET Inhibitor Netarsudil.
Case ReportIrreversible corneal decompensation in patients treated with topical dorzolamide.
Case SeriesBilateral retinal venous occlusion in pigmentary glaucoma.
Case ReportDiagnosis and management of pigmentary glaucoma.
ReviewUltrasound biomicroscopy in pigment dispersion syndrome.
Case SeriesIs this article assigned to the wrong chapter(s)? Let us know.